Law360, New York (September 19, 2013, 2:19 PM EDT) -- The top executive at Swiss drugmaker Roche Holding AG doused reports that his company was lining up financing for a BioMarin Pharmaceutical Inc. takeover play, according to a Thursday report from Bloomberg. DealReporter had suggested Roche was barreling toward a buyout offer for the California company, including seeking out $15 billion in funding to back its move. Roche CEO Severin Schwan played coy on the takeover talk, but said his company does not "have a need" to raise capital.
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.